Early single clinical experience with the new Figulla ASD Occluder for transcatheter closure of atrial septal defect in adults.

CANSEL M., PEKDEMİR H., Yagmur J., Tasolar H., ERMİŞ N., Kurtoglu E., ...More

Archives of cardiovascular diseases, vol.104, no.3, pp.155-60, 2011 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 104 Issue: 3
  • Publication Date: 2011
  • Doi Number: 10.1016/j.acvd.2010.12.006
  • Journal Name: Archives of cardiovascular diseases
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.155-60
  • Keywords: Atrial septal defects, Septal occluder device, PERCUTANEOUS CLOSURE, FORAMEN OVALE, DEVICE, COMPLICATIONS, FEASIBILITY, MULTICENTER, OCCLUSION, IMPLANT, TRIAL, 1ST
  • Bezmialem Vakıf University Affiliated: No

Abstract

Background. Recently, the Occlutech Figulla ASD Occluder (FSO) has been introduced for transcatheter closure of atrial septal defects. This device can be used for transcatheter closure of small as well as large atrial septal defects.